Unknown PHASE4 INTERVENTIONAL 1-arm NCT01768247

HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)

HCG Priming for Thin Endometrium in IVF

Sponsor: Human Reproduction & Genetics Foundation

Conditions Endometrial Thickness Pregnancy Outcome

Interventions HCG (human chorionic gonadotropin)

Updated 5 times since 2017 Last updated: Jan 16, 2013 Started: Jan 31, 2012 Primary completion: Dec 31, 2013 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01768247, this PHASE4 trial focuses on Endometrial Thickness and Pregnancy Outcome and remains ongoing. Sponsored by Human Reproduction & Genetics Foundation, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Human Reproduction & Genetics Foundation
Universitair Ziekenhuis Brussel

Data source: Universitair Ziekenhuis Brussel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Thessaloniki, Greece